Atlas Trials

Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome

Clinical trial NCT02741362 · TERMINATED

Trial details

NCT number
NCT02741362
Sponsor
Arkansas Heart Hospital
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Systemic Lupus ErythematosusRheumatoid ArthritisSharp's Syndrome
Start date
2015-12-01
Primary completion
2016-12-31
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.